[1] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[2] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[3] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[4] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|
[5] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
[6] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[7] |
XU Hongtao, HUANG Xiaojuan, ZHENG Chongyang, ZHANG Zhiyuan.
Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer
[J]. China Oncology, 2023, 33(9): 874-878.
|
[8] |
JU Shenaonan, WANG Yingying, TANG Yong, YAO Yiyun, WU Yingli, ZHU Qi.
Experimental study on sinomenine derivative modulating chemokine receptor in multiple myeloma cells
[J]. China Oncology, 2023, 33(6): 589-596.
|
[9] |
CHEN Luyan, WANG Lixue, FU Peifen.
The value of surgery in the patients with de novo stage Ⅳ breast cancer
[J]. China Oncology, 2023, 33(5): 431-436.
|
[10] |
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang .
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition)
[J]. China Oncology, 2023, 33(4): 403-422.
|
[11] |
ZHENG Shengfeng, ZHU Yiping, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
[J]. China Oncology, 2023, 33(3): 201-209.
|
[12] |
The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association.
Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
[J]. China Oncology, 2023, 33(12): 1092-1187.
|
[13] |
GUO Qinhao, YU Min, WU Xiaohua.
Progress in diagnosis and treatment of gynecological tumors in 2022
[J]. China Oncology, 2023, 33(1): 14-24.
|
[14] |
GAO Heli, XU Jin, YU Xianjun.
Updates on the research and management of pancreatic neuroendocrine neoplasm in 2021
[J]. China Oncology, 2022, 32(9): 772-778.
|
[15] |
LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen.
A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
[J]. China Oncology, 2022, 32(7): 650-656.
|